Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Avantor
NYSE:AVTR Community
1
Narratives
written by author
0
Comments
on narratives written by author
15
Fair Values set
on narratives written by author
Create a narrative
Avantor
Popular
Undervalued
Overvalued
Avantor
WA
Analyst Price Target
Consensus Narrative from 19 Analysts
Divesting Clinical Services And Cost Savings Will Reduce Debt And Improve Margins
Key Takeaways Divesting clinical services and cost-saving initiatives are set to enhance margins, shift focus to high-growth areas, and reduce debt. Commitment to innovation and bioprocessing segment growth suggest a positive outlook for future revenue and earnings.
View narrative
US$26.32
FV
34.3% undervalued
intrinsic discount
2.86%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
AVTR
Avantor
Your Fair Value
US$
Current Price
US$17.30
26.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-415m
8b
2015
2018
2021
2024
2025
2027
2030
Revenue US$7.8b
Earnings US$814.2m
Advanced
Set as Fair Value